31.19 USD
+0.35 (+1.13%)
ChartMill assigns a Buy % Consensus number of 89% to ORKA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 47.75. This target is 53.11% above the current price.
ORKA was analyzed by 18 analysts. The buy percentage consensus is at 89. So analysts seem to be very confident about ORKA.
In the previous month the buy percentage consensus was at a similar level.
ORKA was analyzed by 18 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-13 | BTIG | Maintains | Buy -> Buy |
| 2025-11-13 | Jefferies | Initiate | Buy |
| 2025-10-27 | Guggenheim | Initiate | Buy |
| 2025-10-27 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-10-13 | Barclays | Initiate | Overweight |
| 2025-09-29 | BTIG | Reiterate | Buy -> Buy |
| 2025-09-17 | Clear Street | Maintains | Buy -> Buy |
| 2025-09-17 | BTIG | Maintains | Buy -> Buy |
| 2025-08-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-07-23 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-05-15 | Wedbush | Reiterate | Outperform -> Outperform |
| 2025-02-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-04 | Wolfe Research | Initiate | Outperform |
| 2024-12-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-11 | Stifel | Initiate | Buy |
| 2024-10-07 | HC Wainwright & Co. | Initiate | Buy |
| 2024-09-17 | Leerink Swann | Initiate | Outperform |
| 2024-09-17 | Leerink Partners | Initiate | Outperform |
| 2024-09-16 | LifeSci Capital | Initiate | Outperform |
| 2024-09-16 | TD Cowen | Initiate | Buy |
| 2024-09-13 | Jefferies | Initiate | Buy |
| 2024-09-04 | Wedbush | Initiate | Outperform |
ORUKA THERAPEUTICS INC / ORKA FAQ
Can you provide the average price target for ORUKA THERAPEUTICS INC stock?
18 analysts have analysed ORKA and the average price target is 47.75 USD. This implies a price increase of 53.11% is expected in the next year compared to the current price of 31.19.
What is the consensus rating for ORUKA THERAPEUTICS INC (ORKA) stock?
The consensus rating for ORUKA THERAPEUTICS INC (ORKA) is 88.8889 / 100 . This indicates that analysts generally have a positive outlook on the stock.